Danske Bank’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Danske Bank's BIIB Position: Q3 2026 in Review
Danske Bank increased its Biogen (BIIB) stake by 8.9% in Q3 2026, buying an estimated $1.25M and bringing the position to 72,275 shares worth $16.3M. The position accounts for 0.03% of the portfolio, ranked #359.
Danske Bank first reported a position in BIIB in Q1 2024 and has held it in 11 quarters since. The position peaked at $18.1M in Q1 2024. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Danske Bank held 72,275 shares of Biogen worth $16.3M as of Q3 2026.
- Danske Bank bought 5,910 Biogen shares in Q3 2026, an estimated $1.25M.
- Biogen made up 0.03% of Danske Bank's portfolio in Q3 2026, its #359 holding.
- Danske Bank first reported a position in Biogen in Q1 2024 and has held it in 11 quarters since.
- Danske Bank's Biogen position peaked at $18.1M in Q1 2024.
- 1,062 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.